Noncirrhotic Nonalcoholic Steatohepatitis With Liver Fibrosis: Developing Drugs for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 4, 2018
May 14, 2020
557c8137-5d47-4a52-ab3f-6fd88febd924
Related Documents
Erosive Esophagitis: Developing Drugs for Treatment
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Dry Eye: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentDecember 16, 2020Center for Drug Evaluation and Research
Nonalcoholic Steatohepatitis with Compensated Cirrhosis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentJune 7, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.